They may have left it too late now that China and the emerging markets are falling and there will be less appetite for seeking an ASX Listing.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025